Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03695406 · ClinicalTrials.gov registry record · NA

Mind Body Program for Fear of Recurrence

A NA study of Cancer Survivors, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT03695406 is a NA study of Cancer Survivors that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 23 participants, below the 116-participant average among 11 other Cancer Survivors trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03695406, a NA study of Cancer Survivors, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.

Conditions Studied

Interventions

  • BEHAVIORAL Mind-Body Program for Fear of Recurrence

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medial Center - Boston

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2017-08-09
Est. Completion 2022-01-07
Phase NA

What the Registry Record Tells You About NCT03695406

The ClinicalTrials.gov registry entry for NCT03695406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 11 other Cancer Survivors trials with a reported enrollment target (80% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which Mind-Body Program for Fear of Recurrence is the first listed.

NCT03695406 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03695406 about?

NCT03695406 is a clinical study titled "Mind Body Program for Fear of Recurrence". This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.

What is the current status of trial NCT03695406?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-08-09. Estimated completion is 2022-01-07.

What conditions does trial NCT03695406 study?

This clinical trial studies the following conditions: Cancer Survivors.

What interventions are being tested in trial NCT03695406?

The interventions under investigation include: Mind-Body Program for Fear of Recurrence (BEHAVIORAL).

Who is sponsoring clinical trial NCT03695406?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03695406 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.